JPRN-jRCT2080225002已完成1 期
A Phase 1, Open-label, Single-Dose Study to Investigate the Pharmacokinetics of DSP-6952 in Healthy Elderly and Young Males and Females
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •Healthy males and females who are aged >= 65 and < 80 years in case of elderly subjects or >= 20 and < 40 years in case of young subjects at informed consent etc.
排除标准
- •Subjects with a history of any significant disease such as cardiovascular, hepatic, renal, endocrine, gastrointestinal, hematological, respiratory, central nervous system or psychoneurological disease that is inappropriate for participation in this study in the opinion of the Investigator etc.
研究者
相似试验
进行中（未招募）
不适用
Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis BChronic hepatitis BMedDRA version: 14.1Level: LLTClassification code 10008910Term: Chronic hepatitis BSystem Organ Class: 10021881 - Infections and infestationsEUCTR2007-006218-40-Outside-EU/EEAovartis Pharma Services AG28
已完成
不适用
A Phase I, Open-label, Single Dose Study to Evaluate the Disposition, Metabolism, and Excretion of Radiolabelled [14C]-BIM23B065 Following Subcutaneous Administration in Healthy Male Subjects10014713pituitary tumorpituitary adenomaNL-OMON43034Ipsen Pharmaceuticals6
进行中（未招募）
1 期
A study to evaluate the processing by the body and safety of pralsetinib in participants with hepatic impairment compared to healthy participantsHepatic impairmentDigestive SystemISRCTN38890848Roche (United States)32
进行中（未招募）
1 期
A Phase I, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics and Safety of Telbivudine (LdT) in Children and Adolescents with Chronic Hepatitis B Virus InfectioChronic hepatitis BMedDRA version: 9.1 Level: LLT Classification code 10008910 Term: Chronic hepatitis BEUCTR2007-006218-40-GBovartis Pharma Services AG23
进行中（未招募）
不适用
A Phase I, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics and Safety of Telbivudine (LdT) in Children and Adolescents with Chronic Hepatitis B Virus InfectioChronic hepatitis BMedDRA version: 9.1Level: LLTClassification code 10008910Term: Chronic hepatitis BEUCTR2007-006218-40-DEovartis Pharma Services AG28